SCHEMBL19686989

SCHEMBL19686989

CNC(Cc1cc2ccc(OC)cc2oc1=O)C(C)=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR55 Q9Y2T6 1/20 0.57
ALDH1A1 P00352 4/20 0.55
MAOB P27338 4/20 0.55
GAA P10253 3/20 0.55
HPGD P15428 3/20 0.55
KDM4E B2RXH2 3/20 0.55
GLA P06280 3/20 0.55
HSD17B10 Q99714 1/20 0.55
ADAM17 P78536 2/20 0.55
SLC16A3 O15427 1/20 0.52
NPC1 O15118 4/20 0.50
RAB9A P51151 3/20 0.50
POLB P06746 1/20 0.50
CA12 O43570 1/20 0.50
CA2 P00918 1/20 0.50
CA3 P07451 1/20 0.50
CA4 P22748 1/20 0.50
CA6 P23280 1/20 0.50
CA7 P43166 1/20 0.50
CA9 Q16790 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15179277 1.00 GPR55 (0.57) GPR55ALDH1A1MAOBGAAHPGD
SCHEMBL15179340 0.84 ADAM17 (0.46) GPR55ADAM17POLBMMP2MMP9
SCHEMBL19686993 0.84 ADAM17 (0.46) GPR55ADAM17POLBMMP2MMP9
SCHEMBL15203077 0.83 MAOB (0.57) GPR55ALDH1A1MAOBGAAHPGD
SCHEMBL19419499 0.82 GPR55 (0.60) GPR55ALDH1A1MAOBGAAHPGD
SCHEMBL5293765 0.80 ADAM17 (0.83) GPR55ALDH1A1MAOBGAAHPGD
SCHEMBL11618512 0.77 GPR55 (0.67) GPR55ALDH1A1MAOBGAAHPGD
SCHEMBL12221078 0.77 ALDH1A1 (0.61) ALDH1A1MAOBGAAHPGDKDM4E
SCHEMBL12523188 0.77 GPR55 (0.70) GPR55ALDH1A1MAOBGAAHPGD
SCHEMBL21121524 0.76 GPR55 (0.66) GPR55ALDH1A1MAOBGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170349638-A1 COMPANION DIAGNOSTIC TOOL FOR PEPTIDOMIMETIC MACROCYCLES AILERON THERAPEUTICS, INC. 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170349638-A1 COMPANION DIAGNOSTIC TOOL FOR PEPTIDOMIMETIC MACROCYCLES TP53, TP53BP1, VHL GPR55 3133/4885ALDH1A1 4313/4885MAOB 4842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.